Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

546
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
546
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.1K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

311
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
311
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

497
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
497
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

328
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer-associated synonymous mutations reveal stress signal-dependent mRNA folding that selectively modulates protein function.

RNA (New York, N.Y.)·2026
Same author

The metabolic profiles of cancer stem cells.

Stem cell research & therapy·2026
Same author

A comprehensive European Colorectal Cancer Cohort dataset.

Scientific data·2026
Same author

GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform.

Cellular & molecular biology letters·2026
Same author

From slides to AI-ready maps: Standardized multi-layer tissue maps as metadata for artificial intelligence in digital pathology.

Artificial intelligence in medicine·2026
Same author

Heterogeneity of glucose metabolism and uptake identifies distinct cancer cell and cancer stem cell phenotypes.

Cellular & molecular biology letters·2026

Related Experiment Video

Updated: Jan 25, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
11:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

8.5K

Possible Usage of p63 in Bioptic Diagnostics.

Michaela Galoczová, Rudolf Nenutil, Philip Coates

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |April 27, 2019
    PubMed
    Summary

    The p63 transcription factor and its isoforms, p40 and TAp63, play distinct roles in cell regulation and cancer. Understanding their specific functions is crucial for accurate cancer diagnostics and prognostics, especially in breast and prostate carcinomas.

    Keywords:
    or services used in the study. The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers. Accepted: 17. 8. 2018p63 - DNp63 (p40) - TAp63 - breast carcinoma - prostate carcinoma This work was supported by the project MEYS - NPS I - LO1413. The authors declare they have no potential conflicts of interest concerning drugsproducts

    More Related Videos

    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
    07:06

    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

    Published on: December 1, 2011

    13.7K
    MRM Microcoil Performance Calibration and Usage Demonstrated on Medicago truncatula Roots at 22 T
    10:22

    MRM Microcoil Performance Calibration and Usage Demonstrated on Medicago truncatula Roots at 22 T

    Published on: January 16, 2021

    5.9K

    Related Experiment Videos

    Last Updated: Jan 25, 2026

    Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
    11:02

    Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

    Published on: May 27, 2016

    8.5K
    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
    07:06

    Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

    Published on: December 1, 2011

    13.7K
    MRM Microcoil Performance Calibration and Usage Demonstrated on Medicago truncatula Roots at 22 T
    10:22

    MRM Microcoil Performance Calibration and Usage Demonstrated on Medicago truncatula Roots at 22 T

    Published on: January 16, 2021

    5.9K

    Area of Science:

    • Molecular Biology
    • Cell Biology
    • Oncology

    Background:

    • The p63 transcription factor, a p53 homologue, exhibits diverse functions through various N- and C-terminal isoforms.
    • Key isoforms include DNp63 (p40), a marker for basal cells involved in proliferation and differentiation, and TAp63, which induces apoptosis and maintains genome integrity.

    Purpose of the Study:

    • To review the diagnostic utility and limitations of p63 expression in clinical pathology, particularly for breast and prostate carcinomas.
    • To highlight the potential of isoform-specific antibodies (p40 and TAp63) in improving diagnostic accuracy and understanding tumor behavior.

    Main Methods:

    • Review of existing literature on p63 function, expression patterns, and clinical applications.
    • Discussion of diagnostic pitfalls associated with p63 antibody usage (e.g., 4A4 antibody).

    Main Results:

    • Nuclear p63 expression is a common diagnostic marker for lung, urogenital, breast, and prostate carcinomas.
    • Isoform-specific roles in cancer progression: p40 often acts as an oncoprotein in cancer stem cells, while TAp63 is linked to better prognosis.

    Conclusions:

    • Isoform-specific antibodies for p40 and TAp63 offer potential for more precise diagnostics and prognostics in various cancers.
    • Further research into p63 isoforms can refine histogenetical tumor classification and therapeutic strategies.